Unique ethnic features of <I>DDX41</I> mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
Eun-Ji Choi,
Young-Uk Cho,
Eun-Hye Hur,
Seongsoo Jang,
Nayoung Kim,
Han-Seung Park,
Jung-Hee Lee,
Kyoo-Hyung Lee,
Si-Hwan Kim,
Sang-Hyun Hwang,
Eul-Ju Seo,
Chan-Jeoung Park,
Je-Hwan Lee
Affiliations
Eun-Ji Choi
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Young-Uk Cho
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Eun-Hye Hur
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Seongsoo Jang
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Nayoung Kim
Asan Institution for Life Sciences and Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Han-Seung Park
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Jung-Hee Lee
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Kyoo-Hyung Lee
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Si-Hwan Kim
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Sang-Hyun Hwang
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Eul-Ju Seo
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Chan-Jeoung Park
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul
Je-Hwan Lee
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
DDX41 mutations are associated with hematologic malignancies including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but the incidence in idiopathic cytopenia of undetermined significance (ICUS) is unknown. We investigated the incidence, genetic characteristics, and clinical features of DDX41 mutations in Korean patients with ICUS, MDS, or AML. We performed targeted deep sequencing of 61 genes including DDX41 in 457 patients with ICUS (n=75), MDS (n=210), or AML (n=172). Germline DDX41 mutations with causality were identified in 28 (6.1%) patients, of whom 27 (96.4%) had somatic mutations in the other position of DDX41. Germline origins of the DDX41 mutations were confirmed in all of the 11 patients in whom germline-based testing was performed. Of the germline DDX41 mutations, p.V152G (n=10) was most common, followed by p.Y259C (n=8), p.A500fs (n=6), and p.E7* (n=3). Compared with non-mutated patients, patients with a DDX41 mutation were more frequently male, older, had a normal karyotype, low leukocyte count, and hypocellular marrow at diagnosis. Three of the four ICUS patients with germline DDX41 mutations progressed to MDS. The incidence of DDX41 mutations in Korean patients was high and there was a distinct mutation pattern, in that p.V152G was a unique germline variant. ICUS harboring germline DDX41 mutations may be regarded as a hereditary myeloid neoplasm. Germline DDX41 mutations are not uncommon and should be explored when treating patients with myeloid malignancies.